This article is more than 5 years old. Information may no longer be current.
NuVasive announces limb lengthening system used in first set of patients
Click Here to Manage Email Alerts
NuVasive Inc. announced the new Precice Stryde system for the NuVasive Specialized Orthopedics was used in the first set of patients in procedures performed by Dror Paley, MD, FRCSC, according to a company press release.
The Precice Stryde is a third-generation limb lengthening system that includes an implantable intramedullary nail, locking screws, reusable instruments and a hand-held external remote controller. The system received FDA clearance in April to be used in both the tibia and femur. Patients are reportedly able to non-invasively lengthen or shorten the implant to a prescribed length with the use of an external remote control.
“At [NuVasive Specialized Orthopedics] NSO, we are excited to introduce Precice Stryde to the market, which is just the start of a long line of Precice products in the next 18-months to further transform the orthopedic space and offer better clinical outcomes for patients,” Massimo Calafiore, president of NSO, said in the release. “There is so much opportunity for us to address unmet clinical needs in the orthopedic market — from limb reconstruction to stature lengthening — this latest technology has the ability to drastically improve how our surgeon partners treat their patients.”
NuVasive anticipates a limited launch in mid-2018 and to make the product more broadly available in 2019.
Reference: